Page last updated: 2024-08-17

adenosine monophosphate and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

adenosine monophosphate has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazan, NG; Braquet, PG; Emoto, SE; Esanu, A; Fitzpatrick, JH; Gilboe, DD; Kintner, D1
Evans, RJ; Heath, MF; Jarvis, GE1
Bath, P; Heptinstall, S; Zhao, L1
Anam, EM; Blázquez, MA; Cerdá-Nicolás, M; Cortijo, J; Estellés, R; Issekutz, AC; Ivorra, MD; López-Martín, J; Martínez-Losa, M; Milian, L; Morcillo, EJ; O'Connor, JE; Sanz, MJ1
Holmes, CE; Madsen, NJ; Schneider, DJ; Serrano, FA; Sobel, BE1
Fox, SC; Heptinstall, S; White, AE; Wilcox, RG; Xavier, RG1
Schneider, DJ; Sobel, BE1

Other Studies

8 other study(ies) available for adenosine monophosphate and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists.
    Journal of neurochemistry, 1991, Volume: 56, Issue:1

    Topics: Adenosine Monophosphate; Animals; Azepines; Brain; Creatine; Dimethyl Sulfoxide; Dogs; Electroencephalography; Evoked Potentials, Auditory; Free Radical Scavengers; Glucose; Glycogen; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Kinetics; Oxygen; Phosphocreatine; Platelet Activating Factor; Thienopyridines; Triazoles; Vascular Resistance

1991
The role of ADP in endotoxin-induced equine platelet activation.
    European journal of pharmacology, 1996, Nov-14, Volume: 315, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apyrase; Blood Platelets; Endotoxins; Female; Horses; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Spectrophotometry

1996
Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Communication; Dipyridamole; Drug Synergism; Flow Cytometry; Humans; Leukocytes; Macrophage-1 Antigen; Monocytes; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors

2001
Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
    British journal of pharmacology, 2003, Volume: 140, Issue:6

    Topics: Adenosine Monophosphate; Alkaloids; Animals; Calcium; Cell Communication; Cell Line; Colforsin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Leukocyte Rolling; Leukocytes; Male; Microscopy, Video; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenanthrenes; Plant Extracts; Platelet Activating Factor; Protein Binding; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rolipram

2003
Coleus forskohlii. Monograph.
    Alternative medicine review : a journal of clinical therapeutic, 2006, Volume: 11, Issue:1

    Topics: Adenosine Monophosphate; Cardiovascular Diseases; Coleus; Colforsin; Glaucoma; Hypersensitivity; Obesity; Platelet Activating Factor; Psoriasis

2006
Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    The American journal of cardiology, 2007, Aug-15, Volume: 100, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Benzothiazoles; Blood Platelets; Coronary Disease; Crotalid Venoms; Flow Cytometry; Fluorescent Dyes; Hemostatics; Humans; Lectins, C-Type; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Quinolines; Thrombin; Tirofiban; Tyrosine

2007
Enhanced platelet aggregation and activation under conditions of hypothermia.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Blood Specimen Collection; Citrates; Cold Temperature; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Hirudins; Humans; Hypothermia, Induced; In Vitro Techniques; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Membrane Glycoproteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Tetraspanin 30; Time Factors

2007
Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation.
    Coronary artery disease, 2009, Volume: 20, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Clinical Trials as Topic; Coronary Artery Disease; Crotalid Venoms; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Flow Cytometry; Heparin; Hirudins; Humans; Lectins, C-Type; P-Selectin; Peptide Fragments; Peptides; Pilot Projects; Platelet Activating Factor; Platelet Activation; Platelet Function Tests; Recombinant Proteins; Research Design; Thrombin

2009